• Home
  • About Us
  • Blog

Pulmonary Hypertension RN

  • What is Pulmonary Hypertension?
    • What is Pulmonary Hypertension?
    • Pulmonary Hypertension Symptoms
    • Types of Pulmonary Hypertension
    • Causes of Pulmonary Hypertension
    • PH vs. PAH
    • Diastolic Heart Failure vs. PAH
    • WHO Group 3 Pulmonary Hypertension, IPF & COPD
    • Pulmonary Veno-Occlusive Disease
    • Hereditary Hemorrhagic Telangiectasia (HHT)
      • Hereditary Hemorrhagic Telangiectasia (HHT) Treatment
    • Functional Classification of Pulmonary Hypertension
    • Congenital Heart Disease
      • Eisenmenger’s Syndrome
      • Update on Management of PAH-CHD
      • Congenital Heart Disease & Sleep Apnea
      • Complex Congenital Heart Disease
      • Atrial Septal Defect and Pulmonary Arterial Hypertension
    • Pediatric Pulmonary Arterial Hypertension
    • Sickle Cell and Pulmonary Hypertension
    • Stimulant Associated Pulmonary Arterial Hypertension
    • Porto-Pulmonary Syndrome
    • Research, Life Expectancy & Prognosis for PH
  • Diagnosing & Monitoring PAH
    • Pulmonary Arterial Hypertension Diagnosis
    • How Am I Doing? Assessing Your PAH.
    • Blood Tests
    • Cardiopulmonary Exercise Test (CPET)
    • CT (Computed Tomography) Scan
    • Echocardiogram: An Overview
    • Echocardiogram: A Detailed Look
    • Pulmonary Function Tests (PFTs)
    • Right Heart Catheterization
    • Six Minute Walk
    • Ventilation Perfusion Scan (VQ Scan)
    • CTEPH
      • CTEPH: WHO Group 4 Pulmonary Hypertension
      • PTE (Pulmonary Thromboendarterectomy) Surgery
      • Adempas used to Treat PAH and CTEPH
  • PAH Treatment
    • Pulmonary Hypertension Centers
    • Pulmonary Hypertension Treatments
    • Continuously Infused Therapies Used to Treat PH
    • Prostanoids for Treatment of PH
    • Adcirca and Revatio Used to Treat Pulmonary Arterial Hypertension (PAH)
    • Adempas used to Treat PAH and CTEPH
    • Tracleer, Letairis, and Opsumit Treatments
    • Oxygen Therapy for Pulmonary Hypertension
    • Salt and Water Restrictions
    • Exercise & PAH
    • Diuretics
    • Blood Thinners
    • Getting the Most Out of PAH Therapy
      • Letairis
      • Opsumit
      • Sildenafil (Revatio)
  • Research
  • FAQ’s
    • Implanted Remodulin Pump, Right Heart Catheterization, PAH & Pregnancy
    • Oral Treatments, Care Centers & Hole in Heart
    • FAQ’s: Altitude, Cold & Allergy Medications
    • FAQ’s: Psoriasis, Idiopathic PAH, Contraceptives & PAH
    • FAQ’s: Causes of Pulmonary Hypertension, Symptom Frequency & Care Centers
    • FAQ: PAH Experts, Pregnancy, Mild PAH & Vacationing
    • FAQ’s: CTEPH, Blood Clots, Corrective Surgery & PAH Care Centers
    • FAQ’s: VQ Scans & PAH Curable?
    • FAQ’s: Mild Pulmonary Hypertension?
    • FAQ’s: Boating, Swimming & Eating with PAH
    • FAQ’s: Borderline Pulmonary Hypertension, Hand Swelling, Children with PAH, Costs

Winter Weather Causes Shipping Delays For PAH Medications

January 22, 2014 By Dr. Jeremy Feldman

Delivery of PAH medications

The United States is getting hit with brutal severe winter weather this year and the country held their breath when UPS and FedEx stated that they could not fulfill their Christmas shipping deadlines.  These delays affect the specialty pharmacies shipping directly to pulmonary arterial hypertension patients as well as suppliers shipping to your local pharmacies. … [Read more...]

5 Resolutions for the New Year

January 8, 2014 By Dr. Jeremy Feldman

PAH resolutions

The ball has dropped and the new year has begun.  This is a great opportunity for pulmonary hypertension patients, their caregivers, or anyone with a chronic disease to vow to improve their health this year.  Below are 5 simple resolutions that may help make 2014 a healthier happier year. … [Read more...]

Oral trepsostinil (Remodulin) approved by FDA

December 21, 2013 By Dr. Jeremy Feldman

Update on PAH Treatments

After more than seven years of development and clinical trials, United Therapeutics received approval from the FDA on 12/20/2013 for their oral version of treprostinil (Remodulin).  The new drug will be called Orenitram. … [Read more...]

Celebrating the holidays with pulmonary hypertension

December 18, 2013 By Dr. Jeremy Feldman

Celebrating the holidays with PH

This time of year can be stressful for everyone. There are increased demands on our time and our bodies as we shop, attend or host parties, prepare for and endure holiday travel … [Read more...]

How to complete a medication list

December 5, 2013 By Dr. Jeremy Feldman

Pulmonary hypertension medication list

Treating pulmonary hypertension requires several different types of medications.  Your physician may use diuretics, blood thinners, PDEV inhibitors, ERAs, and or prostacyclin therapies.  In addition other physicians could be adding medications for diseases such as hypertension (high blood pressure), diabetes, or heart arrhythmias.  It is critical to keep an accurate up to date … [Read more...]

« Previous Page
Next Page »

PAH Life Expectancy

PAH Research

Research, Life Expectancy & Prognosis for PH

Major Developments in Pulmonary Hypertension Affecting Prognosis 1.     Approval of

Where to Get Treatment?

CCCs for PAH

Pulmonary Hypertension Centers

Where to get treatment for pulmonary hypertension? Pulmonary arterial hypertension is a

Popular Posts

Pulmonary hypertension and pregnancy

Pregnancy and Pulmonary Hypertension Part 2

By Dr. Jeremy Feldman

The literature has described the risk of pregnancy to the mother as very severe in patients with advanced PAH. 

stimulant drugs associated with pulmonary arterial hypertension

Sotatercept Coming Soon

By Dr. Jeremy Feldman

A new drug is poised to enter the PAH market and offers great promise for patients. This new drug works in a completely

good news in pah

 

Disclaimer

Recent Blog Posts

  • In Memoriam:  Greg Ahearn, MD June 16, 2024
  • Sotatercept (Winrevair) Approved! June 1, 2024
  • Disappointing News for Rodatristat Ethyl October 11, 2023

Categories

Archives